Literature DB >> 21182416

Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Yuling Zhao1, Matthew J Haney, Natalia L Klyachko, Shu Li, Stephanie L Booth, Sheila M Higginbotham, Jocelyn Jones, Matthew C Zimmerman, R Lee Mosley, Alexander V Kabanov, Howard E Gendelman, Elena V Batrakova.   

Abstract

BACKGROUND: We posit that cell-mediated drug delivery can improve transport of therapeutic enzymes to the brain and decrease inflammation and neurodegeneration seen during Parkinson's disease. Our prior works demonstrated that macrophages loaded with nanoformulated catalase ('nanozyme') then parenterally injected protect the nigrostriatum in a murine model of Parkinson's disease. Packaging of catalase into block ionomer complex with a synthetic polyelectrolyte block copolymer precludes enzyme degradation in macrophages.
METHODS: We examined relationships between the composition and structure of block ionomer complexes with a range of block copolymers, their physicochemical characteristics, and loading, release and catalase enzymatic activity in bone marrow-derived macrophages.
RESULTS: Formation of block ionomer complexes resulted in improved aggregation stability. Block ionomer complexes with ε-polylysine and poly(L-glutamic acid)-poly(ethylene glycol) demonstrated the least cytotoxicity and high loading and release rates. However, these formulations did not efficiently protect catalase inside macrophages.
CONCLUSION: Nanozymes with polyethyleneimine- and poly(L-lysine)(10)-poly(ethylene glycol) provided the best protection of enzymatic activity for cell-mediated drug delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21182416      PMCID: PMC3037278          DOI: 10.2217/nnm.10.129

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  27 in total

1.  Protein diffusion in living skeletal muscle fibers: dependence on protein size, fiber type, and contraction.

Authors:  S Papadopoulos; K D Jürgens; G Gros
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Atomic force microscopy imaging and probing of DNA, proteins, and protein DNA complexes: silatrane surface chemistry.

Authors:  Yuri L Lyubchenko; Luda S Shlyakhtenko; Alexander A Gall
Journal:  Methods Mol Biol       Date:  2009

3.  MTT colorimetric assay for testing macrophage cytotoxic activity in vitro.

Authors:  M Ferrari; M C Fornasiero; A M Isetta
Journal:  J Immunol Methods       Date:  1990-08-07       Impact factor: 2.303

4.  Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease.

Authors:  Anna M Brynskikh; Yuling Zhao; R Lee Mosley; Shu Li; Michael D Boska; Natalia L Klyachko; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

5.  Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents.

Authors:  H K Nguyen; P Lemieux; S V Vinogradov; C L Gebhart; N Guérin; G Paradis; T K Bronich; V Y Alakhov; A V Kabanov
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

6.  Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay.

Authors:  D L Daleke; K Hong; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1990-05-24

7.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

8.  RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting.

Authors:  Sanyog Jain; Vivek Mishra; Paramjit Singh; P K Dubey; D K Saraf; S P Vyas
Journal:  Int J Pharm       Date:  2003-08-11       Impact factor: 5.875

9.  Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics.

Authors:  Jihua Liu; Hillevi Bauer; Jon Callahan; Pavla Kopecková; Huaizhong Pan; Jindrich Kopecek
Journal:  J Control Release       Date:  2010-01-04       Impact factor: 9.776

10.  Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages.

Authors:  Lars Thiele; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

View more
  29 in total

1.  Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Authors:  Yuling Zhao; Matthew J Haney; Vivek Mahajan; Benjamin C Reiner; Anna Dunaevsky; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  J Nanomed Nanotechnol       Date:  2011-09-10

2.  Macrophages with cellular backpacks for targeted drug delivery to the brain.

Authors:  Natalia L Klyachko; Roberta Polak; Matthew J Haney; Yuling Zhao; Reginaldo J Gomes Neto; Michael C Hill; Alexander V Kabanov; Robert E Cohen; Michael F Rubner; Elena V Batrakova
Journal:  Biomaterials       Date:  2017-06-18       Impact factor: 12.479

3.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

Review 4.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 5.  Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.

Authors:  Shen Cheng; Susheel Kumar Nethi; Sneha Rathi; Buddhadev Layek; Swayam Prabha
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

Review 6.  Macrophage-based therapeutic strategies in regenerative medicine.

Authors:  Kara L Spiller; Timothy J Koh
Journal:  Adv Drug Deliv Rev       Date:  2017-05-16       Impact factor: 15.470

Review 7.  Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Authors:  Chayanon Ngambenjawong; Heather H Gustafson; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2017-04-25       Impact factor: 15.470

Review 8.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

9.  Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury.

Authors:  Devika S Manickam; Anna M Brynskikh; Jennifer L Kopanic; Paul L Sorgen; Natalia L Klyachko; Elena V Batrakova; Tatiana K Bronich; Alexander V Kabanov
Journal:  J Control Release       Date:  2012-08-10       Impact factor: 9.776

10.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.